Recent Finacing
Recent Raise
Mynosys Cellular Devices develops and sells the Zepto Precision Cataract Surgery platform, an FDA- and internationally-approved automated capsulotomy device, and operates R&D, manufacturing, sales, and training to expand adoption.
